| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/02/2003 | EP1297141A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same |
| 04/02/2003 | EP1297138A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 04/02/2003 | EP1297137A2 Gp286 nucleic acids and polypeptides |
| 04/02/2003 | EP1297135A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 04/02/2003 | EP1297133A2 Gp354 nucleic acids and polypeptides |
| 04/02/2003 | EP1297130A2 G-protein coupled receptors |
| 04/02/2003 | EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 04/02/2003 | EP1297128A2 G-protein coupled receptors |
| 04/02/2003 | EP1297126A1 Nucleotide and amino acid sequences of a cellular inhibitor of the dna replication in the epstein-barr herpes virus |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 04/02/2003 | EP1268832A4 Production of antibodies in transgenic plastids |
| 04/02/2003 | EP1084268B1 Biotechnological production of polyglutaminic acid |
| 04/02/2003 | EP1080206B1 Generation of multiple gene products from chimeric fusion proteins by cleavage with endoproteases |
| 04/02/2003 | EP0758385B1 Chimeric delta-endotoxin expression in pseudomonas fluorescens |
| 04/02/2003 | EP0742820B1 Production of pharmaceutical-grade plasmid dna |
| 04/02/2003 | EP0736605B1 Process for producing proteins |
| 04/02/2003 | EP0728208B1 Tomato xyloglucan endo-transglycosylase |
| 04/02/2003 | EP0716697B1 DIFFERENTIALLY EXPRESSED $i(LEISHMANIA) GENES AND PROTEINS |
| 04/02/2003 | EP0700444B1 Immunotoxins comprising gelonin and an antibody |
| 04/02/2003 | EP0677114B1 Recombinant swinepox virus |
| 04/02/2003 | EP0623169B1 Hepatitis e virus vaccine and method |
| 04/02/2003 | EP0610427B1 Tgf-beta type iii receptor, cdna encoding it and uses therefor |
| 04/02/2003 | EP0561890B1 Dna expression systems based on alphaviruses |
| 04/02/2003 | CN1408023A Pesticidal proteins |
| 04/02/2003 | CN1407993A Gene recombinant antibody and its fragment |
| 04/02/2003 | CN1407108A Genetic engineering recombination strain expression of lactoferritin and use thereof |
| 04/02/2003 | CN1407085A Modular automatic production line for biopharmaceutics |
| 04/02/2003 | CN1406949A Poly peptide-photosensitive pigment protein-15.73 and polynucleotide for encoding it |
| 04/02/2003 | CN1406632A Collagen based composite sponge and production thereof |
| 04/02/2003 | CN1104502C Genes encoding branched-chain alpha-Ketoacid dehydrogenase complex from streptomyces avermitilis |
| 04/02/2003 | CN1104501C Modified human C3 proteins |
| 04/02/2003 | CN1104440C Method for variation of chromatin condensation |
| 04/01/2003 | WO2002029054A1 Novel protein, process for producing the same and use thereof |
| 04/01/2003 | US6541623 Sepsis shock therapy; rheumatic diseases; antiinflammatory agents; nucleotide sequence detector |
| 04/01/2003 | US6541620 Antagonist for tumor necrosis factor; antiinflammatory agents; rheumatic diseases |
| 04/01/2003 | US6541619 Genetic engineering; transforming Escherichia culture product; anticancer agent |
| 04/01/2003 | US6541616 Exterior membrane; nucleotide sequence; induction immunology response |
| 04/01/2003 | US6541612 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation |
| 04/01/2003 | US6541457 Mammalian IAP gene family, primers, probes and detection methods |
| 04/01/2003 | US6541253 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 04/01/2003 | US6541225 Methods and compositions for generating human monoclonal antibodies |
| 04/01/2003 | US6541223 Propagating permissive eukaryotic cells, transiently stressing to increase production of protein, introducing virus stock, incubating, then harvesting viral agent; vaccines, diagnostic assay |
| 04/01/2003 | US6541220 Novel parathyroid hormone (PTH), parathyroid hormone related protein (PTHrP), receptors (PTH1R and PTH3R) isolated from zebrafish; vectors, host cells, recombinant methods for producing; use in identifying receptor agonists, antagonists |
| 04/01/2003 | US6541008 Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof |
| 04/01/2003 | US6541007 Vaccine for Pseudomonas aeruginosa |
| 04/01/2003 | US6540992 Elk ligand (Elk-L) where elk is a member of the tyrosine kinase receptor family; protects against excitotoxicity, especially of the hipocammpal neurons |
| 04/01/2003 | CA2424777A1 Novel protein, process for producing the same and use thereof |
| 04/01/2003 | CA2290906C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 04/01/2003 | CA2235951C Novel uses of mammalian ctla-8 and related reagents |
| 04/01/2003 | CA2109584C Method for production of a whey protein hydrolyzate |
| 04/01/2003 | CA2102129C Growth hormone antagonists |
| 04/01/2003 | CA2101070C Antigen-presenting capsid with fusion ms2-coat protein |
| 04/01/2003 | CA1341426C Process for the manufacture of thrombin inhibitors |
| 03/27/2003 | WO2003029411A2 Novel cyclooxygenase variants and methods of use |
| 03/27/2003 | WO2003025542A2 Immune response associated proteins |
| 03/27/2003 | WO2003025183A2 Random integration of a polynucleotide after in vivo linearization |
| 03/27/2003 | WO2003025182A1 Dna for overexpression of growth hormone and utilization thereof |
| 03/27/2003 | WO2003025179A1 Novel polypeptide, dna thereof and use of the same |
| 03/27/2003 | WO2003025168A1 Novel protein and dna thereof |
| 03/27/2003 | WO2003025163A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
| 03/27/2003 | WO2003025154A2 Methods and compositions for the construction and use of fusion libraries |
| 03/27/2003 | WO2003025150A2 Lipid-associated molecules |
| 03/27/2003 | WO2003025140A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 03/27/2003 | WO2003025133A2 Methods of making glycolmolecules with enhanced activities and uses thereof |
| 03/27/2003 | WO2003025131A2 Protein modification and maintenance molecules |
| 03/27/2003 | WO2003025129A2 Neurotransmission-associated proteins |
| 03/27/2003 | WO2003025117A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 03/27/2003 | WO2003025116A2 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 03/27/2003 | WO2003025016A2 Trk polypeptide purification method |
| 03/27/2003 | WO2003024994A1 Detection and treatment of cancers of the lung |
| 03/27/2003 | WO2003024992A2 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES |
| 03/27/2003 | WO2003024482A1 Crustaceans as production systems for therapeutic proteins |
| 03/27/2003 | WO2003024392A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/27/2003 | WO2003000732A3 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 03/27/2003 | WO2003000012A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
| 03/27/2003 | WO2002100876B1 Dock 3 tumor suppressor gene |
| 03/27/2003 | WO2002098356A3 Ppp2cs as modifiers of the p53 pathway and methods of use |
| 03/27/2003 | WO2002081650A3 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| 03/27/2003 | WO2002079468A3 A method of increasing complementarity in a heteroduplex polynucleotide |
| 03/27/2003 | WO2002068927A3 Using viruses to detect or purify proteins |
| 03/27/2003 | WO2002064799A3 Optimized messenger rna |
| 03/27/2003 | WO2002056829A3 Methods for preparing purified daptomycin |
| 03/27/2003 | WO2002053761A3 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 03/27/2003 | WO2002053717A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/27/2003 | WO2002048358A3 Regulation of human chemokine-like receptor |
| 03/27/2003 | WO2002044377A3 Obp1:a protein selectively expressed in osteoblasts |
| 03/27/2003 | WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 03/27/2003 | WO2002040506A3 Modified clostridial neurotoxins with altered biological persistence |
| 03/27/2003 | WO2002033086A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/27/2003 | WO2002029060A3 Hematopoietin receptors hpr1 and hpr2 |
| 03/27/2003 | WO2002026951A3 Oxidoreductases |
| 03/27/2003 | WO2002024892A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof |
| 03/27/2003 | WO2002022684A3 Transporters and ion channels |
| 03/27/2003 | WO2002016585A3 Imidazoline receptor homologs |
| 03/27/2003 | WO2002012902A3 Split-ubiquitin based reporter systems and methods of their use |
| 03/27/2003 | WO2002012340A3 Transporters and ion channels |
| 03/27/2003 | WO2002000692A3 Pd-l2 molecules: pd-1 ligands and uses therefor |
| 03/27/2003 | WO2001061346A3 Methods for identifying agents causing a lethal phenotype |
| 03/27/2003 | US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders |